Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Where next for the Zika virus?

Research

The southeastern US, including much of Texas through to Florida, has ideal conditions for the spread of Zika virus, according to a new study involving Oxford scientists.

© corlaffra - Shutterstock

Image courtesy of Shutterstock

A large portion of global tropical and subtropical regions have highly suitable environmental conditions and are at the greatest risk. These areas are inhabited by over 2.7 billion people.

Scientists led by the University of Oxford and the Institute for Health Metrics and Evaluation, Seattle, have produced a fine-scale global map of Zika virus transmission. This map was produced by identifying areas of the world with similar environmental and socioeconomic characteristics as areas where the virus has been reported so far. These characteristics include simple weather variables such as precipitation and land cover, but also complex temperature-based virus incubation models. Separate analysis produced range maps for the primary mosquito vector of Zika, Aedes aegypti.

Read more

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

Tinnitus seems linked with sleep – understanding how could bring us closer to finding a cure

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.